| abstract |
Disclosed are a new compound that inhibits IAP and the use thereof. In particular, the present invention relates to a compound which is an IAP inhibitor, or a stereoisomer, tautomer, nitrogen oxide, hydrate, solvate, metabolite, pharmaceutically acceptable salt or prodrug thereof. The present invention also relates to the use of the compound and pharmaceutical composition thereof in the preparation of a drug for treating or preventing diseases caused by IAP disorder, especially the use of same in the preparation of a drug for treating or preventing cancers or hepatitis B virus infection. |